116 related articles for article (PubMed ID: 8566865)
1. Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas.
Jackson PA; Green MA; Marks CG; King RJ; Hubbard R; Cook MG
Gut; 1996 Jan; 38(1):85-9. PubMed ID: 8566865
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas.
Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R
Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998
[TBL] [Abstract][Full Text] [Related]
4. HLA antigens on colorectal adenoma and cancer cells.
Horie Y; Chiba M; Iizuka M; Igarashi K; Masamune O
Tohoku J Exp Med; 1990 Apr; 160(4):311-22. PubMed ID: 2382260
[TBL] [Abstract][Full Text] [Related]
5. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.
Håkansson L; Adell G; Boeryd B; Sjögren F; Sjödahl R
Br J Cancer; 1997; 75(3):374-80. PubMed ID: 9020482
[TBL] [Abstract][Full Text] [Related]
6. Invariant chain expression in colon neoplasms.
Jiang Z; Xu M; Savas L; LeClair P; Banner BF
Virchows Arch; 1999 Jul; 435(1):32-6. PubMed ID: 10431843
[TBL] [Abstract][Full Text] [Related]
7. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
8. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
Smith ME; Marsh SG; Bodmer JG; Gelsthorpe K; Bodmer WF
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5557-61. PubMed ID: 2473473
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
Chung YR; Kim HJ; Jang MH; Park SY
Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
12. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.
Gutierrez J; López-Nevot MA; Cabrera T; Oliva R; Esquivias J; Ruiz-Cabello F; Garrido F
Exp Clin Immunogenet; 1987; 4(3):144-52. PubMed ID: 2856203
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer.
Kasajima A; Sers C; Sasano H; Jöhrens K; Stenzinger A; Noske A; Buckendahl AC; Darb-Esfahani S; Müller BM; Budczies J; Lehman A; Dietel M; Denkert C; Weichert W
Hum Pathol; 2010 Dec; 41(12):1758-69. PubMed ID: 20869097
[TBL] [Abstract][Full Text] [Related]
14. Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.
Lönnroth C; Andersson M; Arvidsson A; Nordgren S; Brevinge H; Lagerstedt K; Lundholm K
Cancer Immun; 2008 Feb; 8():5. PubMed ID: 18307280
[TBL] [Abstract][Full Text] [Related]
15. Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases.
de Miranda NF; Goudkade D; Jordanova ES; Tops CM; Hes FJ; Vasen HF; van Wezel T; Morreau H
Clin Cancer Res; 2012 Mar; 18(5):1237-45. PubMed ID: 22261803
[TBL] [Abstract][Full Text] [Related]
16. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
18. Variation of HLA-ABC surface antigen expression on adenocarcinoma of the colon in correlation with the degree of differentiation.
Eyal A; Levin I; Segal S; Levi I; Klein B; Kuperman O
Nat Immun Cell Growth Regul; 1990; 9(3):222-7. PubMed ID: 2370880
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-DR antigen and characterization of the lymphocytic infiltrate in normal mucosa, tubulo-villous adenoma and invasive carcinoma of the colon.
Tamiolakis D; Venizelos J; Papadopoulos N; Lambropoulou M; Papadopoulos E; Simopoulos C
Chirurgia (Bucur); 2005; 100(5):451-6. PubMed ID: 16372671
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
Chaux P; Moutet M; Faivre J; Martin F; Martin M
Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
